The agent worked around direct site access blocking by assembling a coherent business overview from third-party analyses and search results, but could not access Bayer's official strategy pages or verify current pricing and positioning claims directly from bayer.com.

• ›The target domain bayer.com is actively blocking web fetches (returned 403 Forbidden on both www.bayer.com and bayer.com, and again on the strategy subpath), forcing the agent to rely entirely on external sources — a hard barrier to identity verification.
• ›All four content-bearing steps (5, 9, 11, 13) were web searches that surfaced third-party analyses and business model frameworks; no primary-source site content was retrieved, meaning the agent had no way to confirm whether Bayer's current messaging aligns with these external characterizations.
• ›The agent correctly identified this limitation in its final response and flagged that specific pricing details, customer acquisition models, and current strategy remain unknowable without site access — honest acknowledgment of the gaps.
• ›The search results included links to Bayer's official pages (e.g., 'Our Mission & Strategy | Bayer Global' in step 5), but those URLs also returned 403 when fetched in step 7, confirming systematic blocking rather than temporary outage.
• ›The agent's answer is well-structured and plausible (Bayer is indeed a life sciences conglomerate), but is fundamentally third-party reconstruction rather than direct explanation of what Bayer itself says it does — the task asked to 'read the site and tell me,' which was not possible.